| Identification | Back Directory | [Name]
4-[6-[(8-cyclopentyl-6-ethenyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-piperazinecarboxylic acid tert-butyl ester | [CAS]
1941177-45-2 | [Synonyms]
Palbociclib-020
Palbociclib Impurity 50
4-[6-[(8-cyclopentyl-6-ethenyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-piperazinecarboxylic acid tert-butyl ester
1-Piperazinecarboxylic acid, 4-[6-[(8-cyclopentyl-6-ethenyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-, 1,1-dimethylethyl ester
4-?[6-?[(8-?Cyclopentyl-?6-?ethenyl-?7,?8-?dihydro-?5-?methyl-?7-?oxopyrido[2,?3-?d]?pyrimidin-?2-?yl)?amino]?-?3-?pyridinyl]?-1-?Piperazinecarboxylic Acid 1,?1-?Dimethylethyl Ester | [Molecular Formula]
C29H37N7O3 | [MDL Number]
MFCD28359442 | [MOL File]
1941177-45-2.mol | [Molecular Weight]
531.65 |
| Chemical Properties | Back Directory | [Melting point ]
>220°C (dec.) | [storage temp. ]
Amber Vial, -20°C Freezer, Under inert atmosphere | [solubility ]
Dichloromethane (Slightly, Heated), DMSO (Slightly, Heated, Sonicated) | [form ]
Solid | [color ]
Light Yellow to Dark Beige | [Stability:]
Light Sensitive |
| Hazard Information | Back Directory | [Uses]
4-?[6-?[(8-?Cyclopentyl-?6-?ethenyl-?7,?8-?dihydro-?5-?methyl-?7-?oxopyrido[2,?3-?d]?pyrimidin-?2-?yl)?amino]?-?3-?pyridinyl]?-1-?Piperazinecarboxylic Acid 1,?1-?Dimethylethyl Ester is an impurity of Palbociclib (P139900) an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. |
|
|